Callan JMB Expands Atlas Complex, Advances Recurring Infrastructure Services Business with Cavalry 1838 Equine Biosciences

Agreement reinforces the Atlas Complex strategy while expanding Callan JMB's recurring infrastructure services business through a 60% participation in enterprise revenue. The enterprise's underlying business plan contemplates annual revenue of between $12 million and $25 million within seven years under its base-case scenario.

MARION, AL., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Callan JMB Inc. (NASDAQ: CJMB) ("Callan JMB" or the "Company"), an integrative logistics company empowering the healthcare industry and emergency management agencies through fulfillment, storage, monitoring, and cold chain logistics services, today announced a strategic support services agreement with Cavalry 1838 Equine Biosciences, further expanding the Company's growing portfolio of life sciences infrastructure partnerships.